| abstract |
The present invention is an agent for improving glucose tolerance or an agent for preventing or / or treating a disease caused by abnormal glucose tolerance as an active ingredient. Diseases caused by abnormal glucose tolerance include diabetes and / or diabetic complications, and diabetic complications include diabetic nephropathy, diabetic retinopathy, diabetic peripheral neuropathy, hyperinsulinemia, insulin resistance syndrome, atherosclerosis and cardiac acute tube syndrome , Obstructive atherosclerosis, vasculitis, cerebral infarction, hypertension, renal failure, nephropathy, nephritis, renal aneurysm, kidney infarction, obesity. |